Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)
  12-2023 12-2022 12-2021 12-2020 12-2019
Assets
Current Assets
Cash & Cash Equivalents 2,730,000 3,105,900 2,885,600 2,193,700 1,617,800
Marketable Securities 8,114,800 4,636,400 2,809,100 1,393,300 1,596,500
Receivables 5,667,300 5,328,700 6,036,500 4,114,700 2,785,600
Inventories 2,580,500 2,401,900 1,951,300 1,916,600 1,415,500
TOTAL $19,479,200 $15,884,100 $14,014,900 $9,779,100 $7,689,100
Non-Current Assets
PPE Net 4,146,400 3,763,000 3,482,200 3,221,600 2,890,400
Investments And Advances 5,396,500 6,591,800 6,838,000 3,135,600 3,256,800
Intangibles 1,038,600 915,500 6,700 0 0
Other Non-Current Assets 3,019,500 2,060,100 1,093,000 1,027,000 968,901
TOTAL $13,601,000 $13,330,400 $11,419,900 $7,384,200 $7,116,101
Total Assets $33,080,200 $29,214,500 $25,434,800 $17,163,300 $14,805,200
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 606,600 589,200 564,000 475,500 418,100
Other current liabilities 2,357,900 2,074,200 2,206,800 1,644,200 1,296,400
TOTAL $3,423,400 $3,141,300 $3,932,500 $2,697,400 $2,096,600
Non-Current Liabilities
Long Term Debt 1,982,900 1,981,400 1,980,000 1,978,500 0
Deferred Revenues 458,900 477,900 442,000 577,700 382,100
aiOther Non-Current Liabilities 854,100 638,000 680,200 687,100 799,700
TOTAL $3,683,700 $3,409,200 $2,733,500 $3,440,600 $1,618,900
Total Liabilities $7,107,100 $6,550,500 $6,666,000 $6,138,000 $3,715,500
Shareholders' Equity
Shares Outstanding, K 109,762 109,326 108,539 107,132 110,020
Common Shares 100 100 100 100 100
Retained earnings 27,260,300 23,306,700 18,968,300 10,893,000 7,379,800
Other shareholders' equity -81,300 -239,100 -26,100 29,000 21,200
TOTAL $25,973,100 $22,664,000 $18,768,800 $11,025,300 $11,089,700
Total Liabilities And Equity $33,080,200 $29,214,500 $25,434,800 $17,163,300 $14,805,200
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar